Altair Nanotechnologies President Interviewed by Chemical Market Reporter; Altair Pigment Process Continues to Generate International and Domestic Interest


RENO, Nev., May 13, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that an interview with the company's Present, Dr. Rudi E. Moerck, has been published in the April 28, 2003, issue of Chemical Market Reporter, a publication dedicated to providing the latest chemical business news, including financial reporting and analysis, market updates, new technology, legislative and regulatory issues, plus a comprehensive round-up of special-interest areas.

The article, Nanotechnology: Defining an Emerging Market features interviews from a variety of companies providing nanomaterials and products. Dr. Moerck's interview discusses the multiple uses of Altair's patented processes, which can economically produce both a phase pure titanium dioxide pigment for the approximately $9 billion pigment industry and a wide variety of nanomaterials targeting, pharmaceutical, energy, environmental remediation, thermal coatings and homeland security.

Dr. Moerck noted that the company is currently employing its lanthanum oxide chemistry in the development of new pharmaceuticals, which include RenaZorb(tm), a new drug for phosphate control in kidney dialysis patients. The drug, which has just completed favorable testing in animals, provides a controlled surface area to allow the optimum reaction of RenaZorb with phosphate in the food eaten by patients with renal failure.

In addition to RenaZorb, Altair is applying its nanotechnology to a pharmaceutical delivery system, which will allow for customization to provide the appropriate surface area, percent voids and particle shape to target the desired rate of drug delivery and speed of action.

"The demand for information pertaining to our patented processes, particularly for the manufacturing of Altair's environmentally friendly titanium dioxide pigment (AHPP) and our nano-based pharmaceutical candidate RenaZorb, has increased significantly," commented Dr. Moerck. "In addition to our news releases and project updates, our patented processes for the manufacturing of pure phase titanium dioxide pigment and a wide variety of nanomaterials have appeared in an assortment of publications featuring emerging technologies, homeland security, energy and environmental interests. We also were pleased that our process was included in an exclusive industry report entitled Global Titanium Dioxide Analysis, recently published by UBS Warburg."

ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair's nanoparticle materials, visit www.altairnano.com .

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company's actual results and performance to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the possibilities that the company may be unable to attract additional customers, funded research opportunities, product development opportunities or ventures through its sales and branding campaign, that the company may never earn sufficient revenues to be profitable and that the company's nanoparticle products may not be integrated into any major market groups and products, in addition to other risks identified in the company's most recent Annual Report on Form 10-K, as filed with the SEC.

The Altair Nanotechnologies Inc. company logo can be found at: http://media.primezone.com/prs/single/?pkgid=511



            

Contact Data